Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: HairBall who wrote (1440)	7/11/1998 5:13:00 PM
From: samcat9	Read Replies (2) \| Respond to of 2887

Mantle7 does ask some good questions, but... most, if not all, of his questions are designed to EMPHASIZE weaknesses in ABMI and its products. Certainly, ABMI does have weaknesses and not all of its products are ready to go to market; some products are in the R&D stage, some are somewhere between R&D and testing, some are in the testing stages, and some are being sold. Mantle7 apparently disagrees with ABMI's priorities and its allocation of resources. We must remember that ABMI is still mainly a developmental stage company. It has survived difficult periods, some of which occurred under Dr. Summers' leadership(?), survived the Summers' era, and is moving toward profitability. Mantle7 has some kind of fixation of hero worship of Dr. Summers as evidenced by his earlier posting. Mantle7 seems to believe Dr. Summers has THE answers concerning ABMI. In fact, Dr. Summers' knowledge of ABMI is dated because he has not been an active part of ABMI for some time. One last point. If another company had ABMI's patents and its products, and an established marketing and sales organization (ABMI is working on this), an established distributor network (ABMI is working on this), and more financial resources (ABMI is working on this), its stock would be selling for a Hell of a Lot More than Its $.52 Price (ABMI is working on this, too). SAMCAT